R. Molinet

Targeted α particle immunotherapy for myeloid leukemia

Joseph G. Jurcic, Steven M. Larson, George Sgouros et al. · Blood · 2002 · 465 citations · Full text

Production of Ac-225 from Th-229 for Targeted α Therapy

Christos Apostolidis, R. Molinet, Gert Rasmussen et al. · Analytical Chemistry · 2005 · 210 citations

Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry.

Tuomo Nikula, Michael R. McDevitt, Ronald D. Finn et al. · PubMed · 1999 · 176 citations

Cyclotron production of Ac-225 for targeted alpha therapy11Dedicated to Prof. Dr. Franz Baumgärtner on the occasion of his 75th birthday.

Christos Apostolidis, R. Molinet, J. McGinley et al. · Applied Radiation and Isotopes · 2004 · 162 citations

Clinical Therapeutic, Pharmacology, Experimental Therapeutic +5

High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.

Thomas M. Behr, Martin Béhé, Michael G. Stabin et al. · PubMed · 1999 · 128 citations

Immunology, Low-let Beta Emitters, Dose-limiting Toxicity +17